M&A News: AstraZeneca Expands China Footprint With FibroGen Deal
AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.
FDA posts observations from AstraZeneca site inspection
The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May ...
US CDC Vaccine Advisory Meeting to Be Postponed, Stat News Reports
The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations regarding several vaccines, including GSK's meningococcal vaccine and ...
Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile
(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...
pharmaphorum23h
AstraZeneca files rival to Pemgarda for COVID PrEP
AstraZeneca may have exited the COVID-19 vaccine market, but it is still hoping to protect vulnerable patients with its antibody sipavibart for pre-exposure prophylaxis (PrEP). The drugmaker said ...